Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eisai Plans Sale of Cancer Medicine in the U.S. as Aricept Protection Ends
Eisai Plans Sale of Cancer Medicine in the U.S. as Aricept Protection Ends
Eisai Plans Sale of Cancer Medicine in the U.S. as Aricept Protection Ends
Submitted by
admin
on November 16, 2010 - 11:57am
Source:
Bloomberg
News Tags:
Eisai
Aricept
breast cancer
Eribulin
Headline:
Eisai Plans Sale of Cancer Medicine in the U.S. as Aricept Protection Ends
Do Not Allow Advertisers to Use My Personal information
